Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001385508-23-000073
Filing Date
2023-03-03
Accepted
2023-03-03 09:22:53
Documents
1
Period of Report
2023-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167785335576864.html 4  
1 FORM 4 wf-form4_167785335576864.xml 4 10912
  Complete submission text file 0001385508-23-000073.txt   12476
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Issuer) CIK: 0001385508 (see all company filings)

EIN.: 464744124 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 233 WILSHIRE BLVD. SUITE 280 SANTA MONICA CA 90401
Business Address
Ruth Matthew R. (Reporting) CIK: 0001872022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38193 | Film No.: 23701915